Antitumor effect potentiators
AssigneeMitsubishi Pharma Corporation
InventorsAkihiro Fujii, Hiroshi Tanaka, Makio Otsuki, Takafumi Kawaguchi, Kouichi Oshita
Life of this patent
Estimating the term…
Abstract
When used concurrently with an antitumor agent, a compound having a Rho kinase inhibitory activity, such as (R)-(+)-N-(4-pyridyl)-4-(1-aminoethyl)benzamide, reinforces an antitumor effect of the antitumor agent and is useful as an antitumor effect potentiator. Particularly, a compound having a Rho kinase inhibitory activity used with an antitumor agent in combination can reduce the dose of the antitumor agent, which in turn affords provision of a sufficient effect and/or reduction of side effects.
Claims37
An antitumor effect potentiator comprising a compound having a Rho kinase inhibitory activity as an active ingredient, which reinforces an antitumor effect of an antitumor agent.
A pharmaceutical composition for potentiation of antitumor effect, which comprises a compound having a Rho kinase inhibitory activity and a pharmaceutically acceptable carrier, which reinforces an antitumor effect of an antitumor agent.
A pharmaceutical composition for the treatment of tumor, which comprises a compound having a Rho kinase inhibitory activity, an antitumor agent and a pharmaceutically acceptable carrier.
A method of treating a tumor, which comprises administering a pharmaceutically effective amount of a compound having a Rho kinase inhibitory activity and a pharmaceutically effective amount of an antitumor agent to a patient.
Use of a compound having a Rho kinase inhibitory activity for the production of an antitumor effect potentiator.
Dependencies are inferred from the claim text.